Literature DB >> 29512170

Importance of baseline heart rate as a predictor of cardiac functional recovery in newly diagnosed heart failure with reduced ejection fraction.

Ali Valika1, Kim Paprockas2, Dana Villines2, Maria Rosa Costanzo1.   

Abstract

BACKGROUND: Left ventricular ejection fraction (LVEF) has shown to predict outcomes in patients with heart failure (HF). Left ventricular recovery (LVR) has shown to improve prognosis. HYPOTHESIS: Guideline-directed medical therapy will predict LVR in patients with HF and reduced LVEF.
METHODS: We studied 244 patients with newly diagnosed HF and an LVEF ≤35%. LVR was defined as an increase in LVEF ≥40%. Patients who experienced LVR were compared with those who had persistent left ventricular dysfunction.
RESULTS: Population characteristics included ischemic etiology, 38.1%; baseline LVEF, 23% ±6%; and mean baseline heart rate (HR), 75 ±13 bpm. Guideline-directed medical therapy was achieved as follows: angiotensin-converting enzyme inhibitors, 74.3%; β-blockers (BB), 95.4%; target dosing of angiotensin-converting enzyme inhibitors, 33.7%; target dosing of BB, 40.2%. LVR occurred in 154/244 patients (63.1%). By multivariable analysis, baseline HR ≤70 bpm was the only independent predictor of LVR (odds ratio: 3.39, 95% confidence interval: 1.5-7.5, P = 0.003). Target dosing of BB therapy was predictive of LVR only in the univariate analysis (odds ratio: 1.9, 95% confidence interval: 1.1-3.4, P = 0.03). Furthermore, the composite endpoint of HF hospitalization or mortality occurred less frequently in those who did vs those who did not achieve target BB doses (5.4% vs 16.7%, respectively; P = 0.023).
CONCLUSIONS: The novel findings of our analysis reveal that the only predictor of LVR in this study was a low baseline HR. Early modulation of HR in newly diagnosed HF patients may increase the rates of LVR.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Guideline-Directed Medical Therapy; Heart Rate; Left Ventricular Recovery; Reverse Remodeling

Mesh:

Substances:

Year:  2018        PMID: 29512170      PMCID: PMC6489996          DOI: 10.1002/clc.22937

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  33 in total

Review 1.  CMR imaging assessing viability in patients with chronic ventricular dysfunction due to coronary artery disease: a meta-analysis of prospective trials.

Authors:  Jorge Romero; Xiaonan Xue; Waddy Gonzalez; Mario J Garcia
Journal:  JACC Cardiovasc Imaging       Date:  2012-05

2.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff
Journal:  J Am Coll Cardiol       Date:  2013-06-05       Impact factor: 24.094

Review 3.  Epidemiology and natural history of recovery of left ventricular function in recent onset dilated cardiomyopathies.

Authors:  Michael M Givertz; Douglas L Mann
Journal:  Curr Heart Fail Rep       Date:  2013-12

4.  Redefining Reverse Remodeling: Can Echocardiography Refine Our Ability to Assess Response to Heart Failure Treatments?

Authors:  Ashley A Waring; Sheldon E Litwin
Journal:  J Am Coll Cardiol       Date:  2016-09-20       Impact factor: 24.094

5.  Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients.

Authors:  Scott D Solomon; Nagesh Anavekar; Hicham Skali; John J V McMurray; Karl Swedberg; Salim Yusuf; Christopher B Granger; Eric L Michelson; Duolao Wang; Stuart Pocock; Marc A Pfeffer
Journal:  Circulation       Date:  2005-12-05       Impact factor: 29.690

6.  Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure.

Authors:  B A Groenning; J C Nilsson; L Sondergaard; T Fritz-Hansen; H B Larsson; P R Hildebrandt
Journal:  J Am Coll Cardiol       Date:  2000-12       Impact factor: 24.094

7.  Prediction of global left ventricular functional recovery in patients with heart failure undergoing surgical revascularisation, based on late gadolinium enhancement cardiovascular magnetic resonance.

Authors:  Tammy J Pegg; Joseph B Selvanayagam; Joslin Jennifer; Jane M Francis; Theodoros D Karamitsos; Erica Dall'Armellina; Karen L Smith; David P Taggart; Stefan Neubauer
Journal:  J Cardiovasc Magn Reson       Date:  2010-10-07       Impact factor: 5.364

8.  Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF).

Authors:  Gregg C Fonarow; William T Abraham; Nancy M Albert; Wendy Gattis Stough; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Karen Pieper; Jie Lena Sun; Clyde W Yancy; James B Young
Journal:  Arch Intern Med       Date:  2007-07-23

Review 9.  Analysis of randomized controlled trials on the effect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving beta-blockers.

Authors:  Genevieve Flannery; Rosie Gehrig-Mills; Baki Billah; Henry Krum
Journal:  Am J Cardiol       Date:  2008-02-21       Impact factor: 2.778

10.  Prediction of long-term segmental and global functional recovery of hibernating myocardium after revascularisation based on low dose dobutamine and late gadolinium enhancement cardiovascular magnetic resonance.

Authors:  Sigita Glaveckaite; Nomeda Valeviciene; Darius Palionis; Roma Puronaite; Pranas Serpytis; Aleksandras Laucevicius
Journal:  J Cardiovasc Magn Reson       Date:  2014-10-03       Impact factor: 5.364

View more
  2 in total

1.  Importance of baseline heart rate as a predictor of cardiac functional recovery in newly diagnosed heart failure with reduced ejection fraction.

Authors:  Ali Valika; Kim Paprockas; Dana Villines; Maria Rosa Costanzo
Journal:  Clin Cardiol       Date:  2018-05-14       Impact factor: 2.882

2.  Outcomes of guideline-based medical therapy in patients with acute heart failure and reduced left ventricular ejection fraction: Observations from the Gulf acute heart failure registry (Gulf CARE).

Authors:  Reem K Jan; Alawi Alsheikh-Ali; Arif Al Mulla; Kadhim Sulaiman; Prashanth Panduranga; Wael Al-Mahmeed; Nooshin Bazargani; Jassim Al-Suwaidi; Mohammed Al-Jarallah; Ahmed Al-Motarreb; Amar Salam; Ibrahim Al-Zakwani
Journal:  Medicine (Baltimore)       Date:  2022-06-10       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.